Neda Hashemi Sadraei, MD
Hematology & Oncology · Albuquerque, NMNPI 1326393380
Payments from drug & device makers
Across 428 payments — averaging $3759.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.1M
- AVEO Pharmaceuticals, Inc.$133K
- Sumitomo Pharma America, Inc.$96K
- Eisai Inc.$86K
- Seagen Inc.$62K
- Bristol Myers Squibb$36K
- plus $50K from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 215 | $1,144,854 |
| AVEO Pharmaceuticals, Inc. | 66 | $133,462 |
| Sumitomo Pharma America, Inc. | 13 | $96,049 |
| Eisai Inc. | 86 | $85,995 |
| Seagen Inc. | 10 | $62,485 |
| Bristol Myers Squibb | 1 | $36,000 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $16,910 |
| Novartis | 7 | $16,852 |
| Pfizer | 5 | $6,627 |
| E.r. Squibb & Sons, L.L.C. | 4 | $6,359 |
| AstraZeneca | 2 | $1,913 |
| Exelixis Inc. | 5 | $610 |
| G1 Therapeutics, Inc. | 1 | $182 |
| Johnson & Johnson | 2 | $180 |
| Janssen Scientific Affairs, LLC | 1 | $142 |
| Sanofi-aventis U.S. LLC | 2 | $132 |
| Blue Earth Diagnostics | 1 | $123 |
| Gilead | 1 | $109 |
| Genentech, Inc. | 1 | $40 |
| Springworks Therapeutics, Inc. | 1 | $29 |
| Rigel Pharmaceuticals, Inc. | 1 | $29 |
| Beone Medicines USA, Inc. | 1 | $22 |
| Iovance Biotherapeutics, Inc. | 1 | $21 |
How this compares
$1,609,126 in reported general payments places this provider in the 95th percentile of 54 hematology & oncology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Albuquerque
- Ursa Brown GlabermanAlbuquerque$5M
- Olivier RixeAlbuquerque$1.6M
- Emrullah YilmazAlbuquerque$1.3M
- Erika MaestasAlbuquerque$880K
- Jose AvitiaAlbuquerque$553K
- Jacklyn NemunaitisAlbuquerque$351K
- Barbara McAnenyAlbuquerque$326K
- Zoneddy DayaoAlbuquerque$319K
- Yara AbdouAlbuquerque$294K
- Scott HerbertAlbuquerque$268K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.